Butyltolylquinuclidine
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(2R,3S,4S)-2-butyl-3-p-tolylquinuclidine
|
|
Clinical data | |
Legal status |
|
Identifiers | |
ATC code | none |
PubChem | CID: 9903250 |
ChemSpider | 8013735 |
Chemical data | |
Formula | C18H27N |
Molecular mass | 257.414 g/mol |
|
|
|
|
(verify) |
2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI.[1] It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse,[2] and produces similar effects to cocaine in animal studies, although milder and longer lasting.
References
<templatestyles src="Asbox/styles.css"></templatestyles>
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Stimulants
- Dopamine reuptake inhibitors
- Quinuclidines
- Nervous system drug stubs
Hidden categories: